SCHEMBL1590738

SCHEMBL1590738

CC(C)(CO)n1ccc2c(NC(=O)Cc3ccc(Cl)cc3F)cccc2c1=O

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 5/20 0.45
KMT2A Q03164 5/20 0.41
ANO1 Q5XXA6 2/20 0.39
KCNQ2 O43526 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 4/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NTRK1 P04629 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
S1PR2 O95136 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1590637 0.88 P2RX7 (0.44) P2RX7ANO1KCNQ2POLBNTRK1
SCHEMBL1590455 0.86 P2RX7 (0.54) P2RX7KCNQ2ALDH1A1LMNAMAPT
SCHEMBL1590585 0.84 P2RX7 (0.56) P2RX7ANO1KCNQ2POLBLMNA
SCHEMBL1591890 0.81 P2RX7 (0.61) P2RX7KCNQ2NTRK1
SCHEMBL1590886 0.81 P2RX7 (0.64) P2RX7KMT2ATP53POLBALDH1A1
SCHEMBL1591021 0.81 P2RX7 (0.64) P2RX7KMT2ATP53POLBALDH1A1
SCHEMBL1590568 0.81 P2RX7 (0.57) P2RX7KCNQ2ALDH1A1LMNAMAPT
SCHEMBL1591806 0.80 P2RX7 (0.48) P2RX7ANO1KCNQ2POLBNTRK1
SCHEMBL1590578 0.80 P2RX7 (0.49) P2RX7KMT2ATP53MEN1MAPT
SCHEMBL1590252 0.80 P2RX7 (0.56) P2RX7KCNQ2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US claimed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US claimed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US claimed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. 2011-04-21 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-7816371-B2 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof RENOVIS, INC. (US) 2010-10-19 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof SECOND GENOME, INC. 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225324-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885KMT2A 4614/4885ANO1 1352/4885
US-20110092476-A1 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof P2RX7, P2RX3, P2RX2 P2RX7 1/4885KMT2A 4614/4885ANO1 1352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.